SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-18-061520
Filing Date
2018-11-26
Accepted
2018-11-26 16:15:46
Documents
1
Group Members
FBIO ACQUISITION, INC.LINDSAY A. ROSENWALD, M.D.MICHAEL S. WEISSOPUS POINT PARTNERS MANAGEMENT, LLCOPUS POINT PARTNERS, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tv507824_sc13da.htm SC 13D/A 106613
  Complete submission text file 0001144204-18-061520.txt   108647
Mailing Address 200 VESEY STREET 25TH FLOOR NEW YORK NY 10281
Business Address 200 VESEY STREET 25TH FLOOR NEW YORK NY 10281 212-417-8000
NATIONAL HOLDINGS CORP (Subject) CIK: 0001023844 (see all company filings)

IRS No.: 364128138 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13D/A | Act: 34 | File No.: 005-51125 | Film No.: 181201027
SIC: 6200 Security & Commodity Brokers, Dealers, Exchanges & Services

Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Filed by) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations